Beginning October 2025, Korecyte will join the CreativeDestructionLab (CDL) Health programme in Berlin. CDL brings together pharma experts, investors, and seasoned entrepreneurs to help guide our therapeutic asset’s strategic development.
ESMT, Business University Germany, develops entrepreneurial leaders who think globally and act responsibly. Prioritizing three areas of research and teaching: leadership, innovation, and analytics. These pillars guide its programming, thus providing a sound foundation for the successful performance of CDL-Berlin.
